Gjonbrataj J, Choi W-I, Bahn Y E, Rho B H, Lee J J, Lee C W
Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Republic of Korea; Department of Internal Medicine, Mother Thereza University Hospital, Tirana, Albania.
Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Republic of Korea.
Int J Tuberc Lung Dis. 2015 Jun;19(6):742-6. doi: 10.5588/ijtld.14.0650.
To estimate the annual incidence rate of interstitial lung disease (ILD) and idiopathic pulmonary fibrosis (IPF) in Korea.
A retrospective cohort design using the Korean Health Insurance Review and Assessment Service (HIRA) database spanned the period from January 2008 to December 2012. Patients with ILD and IPF were identified based on the International Classification of Disease-10 (ICD-10) diagnosis and procedure codes. Definition 1 is code J84 (ILD); Definition 2 is code J84 plus high-resolution computed tomography (HRCT), bronchoalveolar lavage (BAL) or lung biopsy; Definition 3 is code J84.1 (ILD with fibrosis); Definition 4 is code J84.1 and HRCT, BAL or lung biopsy; and Definition 5 is code J84.1A (IPF), and was specifically implemented for IPF.
The incidence rates of ILD per 100,000 population based on Definitions 1-5 were respectively 48.5, 32.2, 16.2, 11.4 and 1.7.
The incidence of ILD with fibrosis was approximately 23% of overall ILD incidence. IPF incidence was approximately 10% of the incidence of ILD with fibrosis. Based on the new ATS/ERS/JRS/ALAT statement published in 2011, the incidence rate of IPF was 1.7/100,000.
评估韩国间质性肺疾病(ILD)和特发性肺纤维化(IPF)的年发病率。
采用回顾性队列设计,使用韩国健康保险审查与评估服务(HIRA)数据库,时间跨度为2008年1月至2012年12月。根据国际疾病分类第10版(ICD - 10)诊断和程序编码确定ILD和IPF患者。定义1为编码J84(ILD);定义2为编码J84加上高分辨率计算机断层扫描(HRCT)、支气管肺泡灌洗(BAL)或肺活检;定义3为编码J84.1(伴有纤维化的ILD);定义4为编码J84.1以及HRCT、BAL或肺活检;定义5为编码J84.1A(IPF),专门用于IPF。
基于定义1 - 5,每10万人口中ILD的发病率分别为48.5、32.2、16.2、11.4和1.7。
伴有纤维化的ILD发病率约占总体ILD发病率的23%。IPF发病率约为伴有纤维化的ILD发病率的10%。根据2011年发布的新的美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科协会声明,IPF的发病率为1.7/10万。